Nai Yi Heng, Doeven Egan H, Guijt Rosanne M
Centre for Regional and Rural Futures, Deakin University, Geelong, Victoria, Australia.
PLoS One. 2022 Mar 24;17(3):e0265391. doi: 10.1371/journal.pone.0265391. eCollection 2022.
The uptake of Nucleic Acid Sequence-Based Amplification (NASBA) for point of care testing may be hindered by a complexity in the workflow due the requirement of a thermal denaturation step to initiate the cyclic isothermal amplification before the addition of the amplification enzymes. Despite reports of successful enhancement of other DNA and RNA amplification methods using DNA and RNA binding proteins, this has not been reported for NASBA. Here, three single-stranded binding proteins, RecA, Extreme Thermostable Single-stranded binding protein (ET SSB) and T4 gene gp32 protein (gp32), were incorporated in NASBA protocol and used for single pot, one-step NASBA at 41 °C. Indeed, all SSBs showed significantly improved amplifications compared with the 2-step process, but only gp32 showed no non-specific aberrant amplification, and slightly improved the time-to-positivity in comparison with the conventional NASBA. For synthetic HIV-1 RNA, gp32 was found to improve the time-to-positivity (ttp) by average of 13.6% of one-step NASBA and 6.7% of conventional NASBA for the detection of HIV-1 RNA, showing its potential for simplifying the workflow as desirable for point of care applications of NASBA.
基于核酸序列的扩增技术(NASBA)用于即时检测时,其工作流程的复杂性可能会阻碍该技术的应用。这是因为在添加扩增酶之前,需要进行热变性步骤以启动循环等温扩增。尽管有报道称使用DNA和RNA结合蛋白成功增强了其他DNA和RNA扩增方法,但尚未见NASBA相关报道。在此,将三种单链结合蛋白,即RecA、极端耐热单链结合蛋白(ET SSB)和T4基因gp32蛋白(gp32)纳入NASBA方案,并用于41°C下的单管一步NASBA。事实上,与两步法相比,所有单链结合蛋白均显示出显著改善的扩增效果,但只有gp32未显示非特异性异常扩增,并且与传统NASBA相比,其阳性时间略有缩短。对于合成的HIV-1 RNA,发现gp32在检测HIV-1 RNA时,可使一步NASBA的阳性时间平均缩短13.6%,使传统NASBA的阳性时间平均缩短6.7%,显示出其在简化NASBA即时检测工作流程方面的潜力。